drugset / Trial / NCT01578811

Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

NCT01578811 ↗

Phase 2 Completed 102 enrolled SK Chemicals Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to Assess the Efficacy and Safety of SK-MS10 in subjects With acute and chronic gastritis.

Timeline

Start
2011-08
Primary completion
2012-06
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SK-MS10 Unknown 160 mg —
Subject SK-MS10 Unknown 320 mg —

Indications